| Identification | Back Directory | [Name]
Morusinol | [CAS]
62949-93-3 | [Synonyms]
Morusinol
2-(2,4-dihydroxyphenyl)-5-hydroxy-3-(3-hydroxy-3-methylbutyl)-8,8-dimethylpyrano[2,3-h]chromen-4-one
2-(2,4-Dihydroxy-phenyl)-5-hydroxy-3-(3-hydroxy-3-methyl-butyl)-8,8-dimethyl-8H-benzo[1,2-b:4,3-b]dipyran-4-one
4H,8H-Benzo[1,2-b:3,4-b']dipyran-4-one, 2-(2,4-dihydroxyphenyl)-5-hydroxy-3-(3-hydroxy-3-methylbutyl)-8,8-dimethyl- | [Molecular Formula]
C25H26O7 | [MDL Number]
MFCD20274678 | [MOL File]
62949-93-3.mol | [Molecular Weight]
438.47 |
| Chemical Properties | Back Directory | [Melting point ]
213-214 °C | [Boiling point ]
699.6±55.0 °C(Predicted) | [density ]
1.341±0.06 g/cm3(Predicted) | [storage temp. ]
2-8°C | [solubility ]
Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | [form ]
powder | [pka]
6.58±0.60(Predicted) | [color ]
Yellow |
| Hazard Information | Back Directory | [Uses]
Morusinol is a flavonoid isolated from Morus alba root bark. Morusinol has an antiplatelet activity and ?significantly inhibits arterial thrombosis in vivo[1]. | [Definition]
ChEBI: Morusinol is a member of flavones. | [target]
IL Receptor | TNF-α | NF-kB | [References]
[1] Lee JJ, et al. Morusinol extracted from Morus alba inhibits arterial thrombosis and modulates platelet activation for the treatment of cardiovascular disease.J Atheroscler Thromb. 2012;19(6):516-22. Epub 2012 Apr 4. DOI:10.5551/jat.10058 |
|
| Company Name: |
BioBioPha Co., Ltd.
|
| Tel: |
0871-65217109 13211707573; |
| Website: |
http://www.biobiopha.com |
|